Abstract:Guiming Zhang, 1, &ast Shangcong Han, 2, &ast Lisheng Wang, 3 Yu Yao, 1 Kai Chen, 4 Si Chen 5 1 Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People's Republic of China; 2 Department of Pharmaceutics, School of Pharmacy, Qingdao University, Qingdao, 266021, People's Republic of China; 3 Department of Molecular Diagnosis and Regenerative Medicine, Medical Research Center, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People's Republic of China; 4 Department of Clinical Research, Characteristic Medical Center of Chinese People's Armed Police Force, Tianjin, 300162, People's Republic of China; 5 Department of Anesthesiology, the 991th Hospital of PLA, Xiangyang, 441000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Guiming Zhang, Department of Urology, The Affiliated Hospital of Qingdao University, Qingdao, 266003, People's Republic of China, Email Purpose: This study aimed to construct a delivery system based on L-arginine-modified calcium phosphate (CaP) to load eNOS plasmids (peNOS), which could amply nitric oxide (NO) to repair endothelial damage, promote angiogenic activities and alleviate inflammation. Methods: pDNA-loaded CaP nanocomplex (CaP/pDNA) were prepared by co-precipitation method, subsequently modified by L-arginine. The gene transfection efficiency, pro-angiogenic and anti-inflammatory ability were investigated in vivo and in vitro. The therapeutic effect on ischemic hindlimb in vivo was assessed. Results: L-arginine modification augmented the transfection efficiency of CaP/peNOS to elevate the eNOS expression, and then served as NO substrate catalyzed by eNOS. At the same time, calcium ions produced by degradation of CaP carriers enhanced the activity of eNOS. In vitro experiments, the loading capability and transfection performance of R(L)-CaP were confirmed to be superior to that of CaP. Additionally, HUVECs treated with R(L)-CaP/peNOS showed the strongest NO release, cell migration, tube formation and the lowest inflammatory levels compared to the CaP/peNOS and R(D)-CaP/peNOS groups. We also demonstrated the advantages of R(L)-CaP/peNOS in increasing blood reperfusion in hindlimb ischemia mice by accelerating angiogenesis and reducing inflammation, which can be attributed to the highest eNOS-derived NO production. Conclusion: The combination strategy of peNOS transfection, L-arginine supplement and calcium ions addition is a promising therapeutic approach for certain vascular diseases, based on the synergistic NO production. Keywords: gene delivery, nitric oxide, L-arginine, calcium ion, angiogenesis Endothelial dysfunction can trigger and exacerbate a variety of vascular diseases, such as atherosclerosis. 1,2 Atherosclerotic plaques in lower extremity arteries tend to lead to inadequate distal blood supply and, in severe cases, to critical limb ischemia (CLI). 3,4 Accelerating vascular endothelial cells (VECs)-dominant vascular regeneration and alleviating excessive inflammation in affected extremities are effective approaches for the treatment of CLI. 5 Normal VECs regulate vascular tone and maintain vascular functions by acting as a physical barrier and secreting vasodilatory substances, anticoagulants, anti-inflammatory cytokines, and many other active components. As a multifunctional gas signaling molecule released by VECs, nitric oxide (NO) was originally identified as a vasodilator and has been shown to inhibit platelet adhesion and smooth muscle cells (SMCs) proliferation, promote VECs morphogenesis, and reduce inflammatory response. 6 The decrease in NO bioavailability is considered as one of the most important causes of endothelial dysfunction. 7 Hence, a moderate increase in NO levels produced by VECs and their bioavailability is of vital significance in mitigating CLI processes through repairing endothelial damage, enhancing VECs angiogenic activities and reducing pro-inflammatory cytokines. 8,9 Administration of exogenous NO donors can successfully up-regulate intracellular NO levels; however, existing NO donors suffer from deficiencies including disappointing drug release performance, poor bioavailability, and unignored side effects. 10,11 Thoroughly understanding the synthesis mechanism of endogenous NO is valuable for artificially up-regulating its production. 12 Undoubtedly, NO in VECs is generally produced by endothelial nitric oxide synthase (eNOS) catalyzing L-arginine. A growing body of researches is devoted to promoting the release of endogenous NO. -Abstract Truncated-

Nitric Oxide Increases Arterial Endotheial Permeability Through Mediating VE-Cadherin Expression During Arteriogenesis.

Norepinephrine Stimulates Mobilization of Endothelial Progenitor Cells after Limb Ischemia

Expression of endothelial nitric oxide synthase in the vascular wall during arteriogenesis

Effects of endogenous nitric oxide and of DETA NONOate in arteriogenesis

Direct Evidence for Endothelial Vascular Endothelial Growth Factor Receptor-1 Function in Nitric Oxide-Mediated Angiogenesis

Effects of adventitia-derived nitric oxide on the proliferation of vascular smooth muscle induced by endotheline-1

Arteriogenesis: role of nitric oxide

Adventitial Fibroblast-Derived Vascular Endothelial Growth Factor Promotes Vasa Vasorum-Associated Neointima Formation And Macrophage Recruitment

A7900 Adventitial Fibroblast-derived VEGF Promotes Vasa Vasorum-associated Neointima Formation by Macrophage Recruitment

Notch-Dependent Regulation of the Ischemic Vasodilatory Response—Brief Report

Effects of endothelial nitric oxide synthase gene transfection on neointima hyperplasia after vascular injury

Perivascular gene transfer of NADPH oxidase inhibitor suppresses angioplasty-induced neointimal proliferation of rat carotid artery.

Time Course of Nuclear Factor-κB activation and Vascular Cell Adhesion Molcular-1 Expression in Rat Artery After Endothelium Denudation

Nitric oxide releasing nanofiber stimulates revascularization in response to ischemia via cGMP-dependent protein kinase

Α1-Adrenergic Receptors Mediate Combined Signals Initiated by Mechanical Stretch Stress and Norepinephrine Leading to Accelerated Mouse Vein Graft Atherosclerosis.

A Ternary Synergistic eNOS Gene Delivery System Based on Calcium Ion and L-Arginine for Accelerating Angiogenesis by Maximizing NO Production

Dissecting VEGF-induced acute versus chronic vascular hyperpermeability: Essential roles of dimethylarginine dimethylaminohydrolase-1

Macrophages Activate Inos Signaling in Adventitial Fibroblasts and Contribute to Adventitia Fibrosis

Angiotensin II Directly Increases Endothelial Calcium and Nitric Oxide in Kidney and Brain Microvessels In Vivo With Reduced Efficacy in Hypertension

Accelerated Arteriosclerosis of Vein Grafts in Inducible NO Synthase −/− Mice is Related to Decreased Endothelial Progenitor Cell Repair

Vitronectin Increases Vascular Permeability by Promoting Ve-Cadherin Internalization at Cell Junctions